To define recommendations that permit safe management of antineoplastic medication, minimise medication errors and improve the safety of cancer patients undergoing treatment.
By reviewing the literature and consulting the websites of various health organisations and agencies, an expert committee from the Spanish Society of Hospital Pharmacy and the Spanish Society of Medical Oncology defined a set of safe practices covering all stages of providing cancer therapy to patients. The Spanish Society of Oncology Nursing revised and endorsed the final list.
In total, 68 recommendations arranged in five sections were defined. They include issues concerning the training of health professionals, the technological resources needed, treatment planning, informing the patient and his/her family, the processes of prescribing, preparing, dispensing and administering cancer therapy (orally, parenterally or intrathecally), assessing patient adherence and treatment toxicity.
It is essential for healthcare establishments to implement specific measures designed to prevent medication errors, in order to ensure the safety of cancer patients treated with antineoplastic medication.
Schwappach DL, Wernli M. Medication errors in chemotherapy: incidence, types and involvement of patients in prevention. A review of the literature. Eur J Cancer Care (Engl). 2010;19:285–92. CrossRef
Marliot G, Le Rhun E, Sakji I, Bonneterre J, Cazin JL. Securing the circuit of intrathecally administered cancer drugs: example of a collective approach. J Oncol Pharm Pract. 2011;17:252–9. CrossRef
Markert A, Thierry V, Kleber M, Behrens M, Engelhardt M. Chemotherapy safety and severe adverse events in cancer patients: strategies to efficiently avoid chemotherapy errors in in- and outpatient treatment. Int J Cancer. 2009;124:722–8. CrossRef
Jaehde U, Liekweg A, Simons S, Westfeld M. Minimising treatment-associated risks in systemic cancer therapy. Pharm World Sci. 2008;30:161–8. CrossRef
Easty AC, Coakley N, Cheng R, Cividino M, Savage P, Tozer R, et al. Safe handling of cytotoxics: guideline recommendations. Curr Oncol. 2015;22:e27–37. CrossRef
Gramage Caro T, Palomar Fernández C, Pueyo López C, Sánchez Cuervo M, Gómez de Salazar ME, Bermejo Vicedo T. Validating a classification scheme for medication errors to be used in chemotherapy. Farm Hosp. 2011;35:197–203. CrossRef
Saad A, Der-Nigoghossian CA, Njeim R, Sakr R, Salameh P, Massoud M. Prescription errors with chemotherapy: quality improvement through standardized order templates. Asian Pac J Cancer Prev. 2016;17:2329–36. CrossRef
Trudeau M, Green E, Cosby R, Charbonneau F, Easty T, Ko Y, et al. Key components of intravenous chemotherapy labeling: a systematic review and practice guideline. J Oncol Pharm Pract. 2011;17:409–24. CrossRef
Ng T, Badry N, de Lemos ML. Rationalizing the use of auxiliary label for oral oncology drugs. J Oncol Pharm Pract. 2017;23:338–43. CrossRef
Trudeau M, Green E, Cosby R, Charbonneau F, Easty T, Ko Y et al. Patient safety Issues: key components of chemotherapy labelling. In: Toronto (ON): cancer care ontario. Program in evidence-based Care practice guideline. 2009. https://www.cancercareontario.ca/sites/ccocancercare/files/guidelines/summary/pebc12-11s.pdf. Accessed 11 April 2018.
Dobish R, Shultz J, Neilson S, Raven A, Chambers CR. Worksheets with embedded checklists support IV chemotherapy safer practice. J Oncol Pharm Pract. 2016;22:142–50. CrossRef
Gandhi S, Tyono I, Pasetka M, Trudeau M. Evaluating an oncology systemic therapy computerized physician order entry system using international guidelines. J Oncol Pract. 2014;10:e14–25. CrossRef
Kukreti V, Cosby R, Cheung A, Lankshear S. ST computerized prescriber order entry guideline development group. Computerized prescriber order entry in the outpatient oncology setting: from evidence to meaningful use. Curr Oncol. 2014;21:e604–12. CrossRef
Ortiz-Martin B, Pena-Cabia S. Degree of technological implementation in intravenous chemotherapy management in hospitals of the autonomous community of Madrid. Farm Hosp. 2017;41:488–96. PubMed
Shulman LN, Miller RS, Ambinder EP, Yu PP, Cox JV. Principles of safe practice using an oncology EHR system for chemotherapy ordering, preparation, and administration, part 2 of 2. J Oncol Pract. 2008;4:254–7. CrossRef
Kullberg A, Larsen J, Sharp L. ‘Why is there another person’s name on my infusion bag?’ Patient safety in chemotherapy care—a review of the literature. Eur J Oncol Nurs. 2013;17:228–35. CrossRef
Bubalo J, Warden BA, Wiegel JJ, Nishida T, Handel E, Svoboda LM, et al. Does applying technology throughout the medication use process improve patient safety with antineoplastics? J Oncol Pharm Pract. 2014;20:445–60. CrossRef
Casiraghi A, Franzè S, Rocco P, Minghetti P. Risk management of in-hospital administration of anticancer drugs: impact of raccomandazione 14 from the Italian ministry of health. Tumori. 2016;102:2–6. CrossRef
Carrington C, Stone L, Koczwara B, Searle C, Siderov J, Stevenson B, et al. The clinical oncological society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy. Asia Pac J Clin Oncol. 2010;6:220–37. CrossRef
Leung M, Bland R, Baldassarre F, Green E, Kaizer L, Hertz S et al. Safe administration of systemic cancer therapy: introduction and general methods. In: Toronto (ON): cancer care Ontario. Program in evidence-based care practice guideline. 2012. https://www.cancercareontario.ca/sites/ccocancercare/files/guidelines/full/pebc12-12f.pdf. Accessed 11 April 2018.
Leung M, Bland R, Baldassarre F, Green E, Kaizer L, Hertz S et al. Safe administration of systemic cancer therapy. Part 1: safety during chemotherapy ordering, transcribing, dispensing, and patient identification. In: Toronto (ON): cancer care Ontario. Program in evidence-based care practice guideline. 2012. https://www.cancercareontario.ca/sites/ccocancercare/files/guidelines/summary/pebc12-12-1s.pdf. Accessed 11 April 2018.
Leung M, Bland R, Baldassarre F, Green E, Kaizer L, Hertz S et al. Safe administration of systemic cancer therapy. Part 2: administration of chemotherapy and management of preventable adverse events. In: Toronto (ON): cancer care Ontario. Program in evidence-based care practice guideline. 2014. https://www.cancercareontario.ca/sites/ccocancercare/files/guidelines/summary/pebc12-12-2s.pdf. Accessed 11 April 2018.
Scottish Government. Guidance for the safe delivery of systemic anti-cancer therapy. 2012. http://www.sehd.scot.nhs.uk/mels/CEL2012_30.pdf. Accessed 11 April 2018.
Neuss MN, Gilmore TR, Belderson KM, Billett AL, Conti-Kalchik T, Harvet BE, et al. 2016 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards, including standards for pediatric oncology. Oncol Nurs Forum. 2017;44:31–43. CrossRef
Neuss MN, Polovich M, McNiff K, Esper P, Gilmore TR, LeFebvre KB, et al. 2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy. J Oncol Pract. 2013;9:5s–13s. CrossRef
Jacobson JO, Polovich M, McNiff KK, LeFebvre KB, Cummings C, Galioto M, et al. American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards. Oncol Nurs Forum. 2009;36:651–8. CrossRef
Goldspiel B, Hoffman JM, Griffith NL, Goodin S, DeChristoforo R, Montello CM, et al. ASHP guidelines on preventing medication errors with chemotherapy and biotherapy. Am J Health Syst Pharm. 2015;72:e6–35. CrossRef
Greenall J, Shastay A, Vaida AJUD, Johnson PE, O’Leary J, et al. Establishing an international baseline for medication safety in oncology: findings from the 2012 ISMP international medication safety self assessment(R) for oncology. J Oncol Pharm Pract. 2015;21:26–35. CrossRef
ISMP Canada. ISMP International Medication Safety Self Assessment for Oncology. 2012. https://mssa.ismp-canada.org/data/oncology/mssa_oncology.pdf. Accessed 11 April 2018.
Gilmore TR, Schulmeister L, Jacobson JO. Quality oncology practice initiative certification program: measuring implementation of chemotherapy administration safety standards in the outpatient oncology setting. J Oncol Pract. 2013;9:14s–8s. CrossRef
Griffin MC, Gilbert RE, Broadfield LH, Easty AE, Trbovich PL, Griffin MC, et al. ReCAP: comparison of independent error checks for oral versus intravenous chemotherapy. J Oncol Pract. 2016;12(168–9):e80–7.
Ribed A, Escudero-Vilaplana V, Romero-Jiménez RM, Iglesias-Peinado I, Herranz-Alonso A, Sanjurjo-Séez M. Guiding pharmacist clinical interviews: a safety tool to support the education of patients treated with oral antineoplastic agents. Expert Opin Drug Saf. 2016;15:427–35. CrossRef
Lester J. Safe handling and administration considerations of oral anticancer agents in the clinical and home setting. Clin J Oncol Nurs. 2012;16:E192–7. CrossRef
Goodin S, Griffith N, Chen B, Chuk K, Daouphars M, Doreau C, et al. Safe handling of oral chemotherapeutic agents in clinical practice: recommendations from an international pharmacy panel. J Oncol Pract. 2011;7:7–12. CrossRef
Rudnitzki T, McMahon D. Oral agents for cancer: safety challenges and recommendations. Clin J Oncol Nurs. 2015;19:41–6. CrossRef
Grupo de Farmacia Oncológica de la SEFH. Plan estratégico de atención farmacéutica al paciente oncohematológico. 2016. http://gruposdetrabajo.sefh.es/gedefo/images/stories/documentos/2016/plan%20estratgico%202020.pdf. Accessed 11 April 2018.
Arcusa Lanza A, León Carbonero AI, Vera García R, Juan Vidal OJ, Del Barco Berrón S, Guillot Morales M et al. Hospitales de día en Oncología. Sociedad Española de Oncología Médica. 2015. https://www.seom.org/seomcms/images/stories/recursos/Libro_Hospitales_Dia_en_Oncologia.pdf.
Jara C, Ayala F, Virizuela JA. Oncology day hospital task force. The oncology day hospital in Spain: an updated analysis of Spanish Society of Medical Oncology (SEOM) looking forward. Clin Transl Oncol. 2017;19:269–72. CrossRef
Jacobson JO, Polovich M, Gilmore TR, Schulmeister L, Esper P, Lefebvre KB, et al. Revisions to the 2009 American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards: expanding the scope to include inpatient settings. J Oncol Pract. 2012;8:2–6. CrossRef
North Wales Cancer Network. Standards for the safe use of oral anticancer medicines. 2008. http://www.wales.nhs.uk/sites3/docopen.cfm?orgid=456&id=99534. Accessed 11 April 2018.
- Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients
M. J. Otero
F. Ayala de la Peña
J. M. Sepúlveda
J. A. Virizuela
M. Q. Gorgas
- Springer International Publishing
Clinical and Translational Oncology
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
Neu im Fachgebiet Onkologie
Mail Icon II